Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Inclusion Criteria:

• Male or female

• 3 years of age or older

• Has XLRP confirmed by a retinal specialist and has a predicted disease-causingsequence variant in RPGR confirmed by an accredited laboratory

Exclusion Criteria:

• Has had ocular surgery within 3 months prior to screening or is anticipated torequire ocular surgery within 6 months after the study intervention administration

• Any investigational ocular treatment or any other ocular treatment that couldconfound the interpretation of the efficacy results or affect participant compliancewith the visit schedule

• Has undergone prior retinal surgery involving the macula, macular laserphotocoagulation, external-beam radiation therapy, transpupillary thermotherapy,glaucoma filtration surgery or corneal surgery